Non-HDL cholesterol from total cholesterol and HDL
Enter total cholesterol and HDL from the same lipid panel, in the same unit. Non-HDL is simply the first minus the second, and it does not need a fasting sample.
Educational tool, not a diagnosis. Categories are the adult classification of the National Lipid Association (2014). Your own goal depends on your overall cardiovascular risk, which is for your clinician to assess: people at very high risk are usually given a goal below 100 mg/dL. Non-HDL counts the cholesterol in all atherogenic particles, but not their number, which is what ApoB measures.
What is non-HDL cholesterol?
HDL is the one lipoprotein on a standard panel that is not thought to drive plaque. Everything else that carries cholesterol through the blood, LDL, VLDL and its remnants, intermediate-density lipoprotein, chylomicron remnants and Lp(a), can enter the artery wall. Non-HDL cholesterol adds all of that up in a single number, which is why the National Lipid Association describes it as the cholesterol carried by all potentially atherogenic particles.
Non-HDL cholesterol = total cholesterol − HDL cholesterol
Many labs do not print it, but it costs nothing to calculate: both inputs are on every basic lipid panel. Use values from the same draw and in the same unit. Because it is a subtraction, the unit does not change the arithmetic; mmol/L results convert to mg/dL with the cholesterol factor of 38.67.
Non-HDL cholesterol calculation: worked examples
| Total cholesterol | HDL | Calculation | Non-HDL |
|---|---|---|---|
| 180 mg/dL | 55 mg/dL | 180 − 55 | 125 mg/dL (desirable) |
| 200 mg/dL | 60 mg/dL | 200 − 60 | 140 mg/dL (above desirable) |
| 220 mg/dL | 50 mg/dL | 220 − 50 | 170 mg/dL (borderline high) |
| 250 mg/dL | 40 mg/dL | 250 − 40 | 210 mg/dL (high) |
| 5.4 mmol/L | 1.3 mmol/L | 5.4 − 1.3 | 4.1 mmol/L, about 159 mg/dL (above desirable) |
Non-HDL cholesterol normal range
The categories below are the adult classification published by the National Lipid Association in its 2014 recommendations for the management of dyslipidemia (Jacobson and colleagues, Journal of Clinical Lipidology). They are population categories, not personal targets.
| Non-HDL cholesterol | Category |
|---|---|
| Under 130 mg/dL (under 3.36 mmol/L) | Desirable. Also the NLA goal for people at low, moderate and high risk. |
| 130–159 mg/dL (3.36–4.11 mmol/L) | Above desirable. |
| 160–189 mg/dL (4.14–4.89 mmol/L) | Borderline high. |
| 190–219 mg/dL (4.91–5.66 mmol/L) | High. Listed as a risk-enhancing factor in the 2018 AHA/ACC cholesterol guideline. |
| 220 mg/dL and above (5.69 mmol/L and above) | Very high. |
Why non-HDL runs 30 mg/dL above LDL
The US National Cholesterol Education Program’s Adult Treatment Panel III (2001) introduced non-HDL cholesterol as a secondary target for people with triglycerides of 200 mg/dL or more, and set each non-HDL goal 30 mg/dL above the matching LDL goal: 130 against 100, 160 against 130, 190 against 160. The 30 mg/dL reflects the cholesterol normally carried in VLDL when triglycerides are in the normal range. The NLA bands follow the same logic, which is why each one sits 30 mg/dL above the familiar LDL category. A non-HDL of 160 to 189 mg/dL is the counterpart of the borderline-high LDL of 130 to 159 mg/dL.
Reading your result
Non-HDL cholesterol is a risk marker, not a diagnosis, and the same number means different things for different people. The 2018 AHA/ACC multisociety cholesterol guideline (Grundy and colleagues, Circulation 2019) sets treatment decisions by overall risk, combining age, blood pressure, smoking, diabetes and other factors, with cholesterol as one input among several. A value of 150 mg/dL can be unremarkable in a 35-year-old with no other risk factors and above goal in someone who has already had a heart attack, for whom the NLA suggests below 100 mg/dL and the 2018 guideline uses 100 mg/dL as a threshold when considering added therapy.
The gap between your non-HDL and your LDL is informative in its own right. When non-HDL is much more than 30 mg/dL above LDL, the extra cholesterol is usually in triglyceride-rich particles, the pattern that goes with high triglycerides, insulin resistance and excess liver fat. That is exactly when LDL alone tends to understate risk, and why a total cholesterol of 220 can mean very different things depending on what sits behind it. The cholesterol ratio is another way of reading the same two inputs.
It is also an imprecise number. Total cholesterol and HDL each carry analytical and biological variation, and subtracting one from the other does not cancel it, so a difference of 10 mg/dL between two panels can be noise. One reading is a snapshot; a trend across several draws, taken under similar conditions, is what carries weight.
No fasting needed
Total cholesterol and HDL barely change after a meal, so non-HDL is reliable on a nonfasting sample. The NLA notes that neither non-HDL cholesterol nor ApoB requires fasting for accurate assessment, and the 2018 AHA/ACC guideline accepts a nonfasting lipid profile for estimating risk in adults. Triglycerides, and an LDL calculated from them, are the values a recent meal moves.
Non-HDL cholesterol and ApoB
Every atherogenic particle carries one molecule of apolipoprotein B, so ApoB counts the particles while non-HDL cholesterol weighs the cholesterol inside them. The two are closely correlated, more closely than LDL and ApoB, which is why the NLA prefers non-HDL to LDL as a primary target and treats ApoB as an optional secondary one. They can still disagree, especially when particles are small and cholesterol-poor; in that case ApoB is the more direct measure. The detail is in ApoB and heart disease risk. If your lab reports in mmol/L, the cholesterol converter handles every lipid on the panel.
Already have your bloodwork? Merios reads it next to your watch data.